文献速递乳腺病理

乳腺非典型大汗腺病变的组织形态学分析与临床相关性

Histomorphologic analysis and clinical correlation of atypical apocrine lesions in breast pathology.
PubMed 文献 · Hum Pathol · 2026-05-22

该回顾性研究分析了59例2014至2024年间初诊为非典型大汗腺腺病(AAA)或非典型大汗腺增生(AAH)的标本,排除合并原位或浸润性导管癌者。结果显示筛状结构在AAH中更常见,而病变范围大、显著核增大、核不规则和坏死与癌升级独立相关,提示应警惕大汗腺DCIS。

要点

  • 筛状结构支持AAH分类,但AAA与AAH临床无显著差异
  • 病变范围大、核不规则和坏死独立关联癌升级
  • 显著核增大、核不规则和坏死应提示大汗腺DCIS

核心结论

  • 筛状结构支持分类为AAH,但AAA与AAH无显著临床差异。
  • 较大非典型大汗腺病变中显著核增大、核不规则和坏死与癌升级强相关。
  • 上述特征应促使考虑大汗腺DCIS。

研究设计与样本

  • 回顾性分析59例2014至2024年初诊为AAA或AAH(含非典型大汗腺导管增生)的标本。
  • 排除合并原位或浸润性导管癌的病例。
  • 复习组织学特征和临床随访数据。

主要发现

  • 筛状结构在AAH中显著多于AAA(63% vs. 33%,p=0.047)。
  • 升级为原位或浸润性导管癌者活检中非典型范围显著更大(1.3 cm vs. 0.8 cm,p=0.043)。
  • 升级者显著核增大(≥3倍背景上皮)频率更高(92% vs. 54%,p=0.027)。
  • 升级者核不规则频率更高(54% vs. 17%,p=0.028)。
  • 升级者坏死频率更高(23% vs. 0%,p=0.037)。

关键数值与推荐

  • 病变范围、核不规则和坏死独立关联癌升级(p<0.05)。
  • AAA与AAH在患者年龄、病变大小、多数结构模式、小叶累及、核特征、坏死、钙化或后续切除癌升级方面无显著差异。

临床怎么用

  • 活检中非典型大汗腺病变范围大、伴显著核增大、核不规则或坏死时,应警惕癌升级并考虑大汗腺DCIS。
  • 筛状结构可支持AAH分类,但AAA与AAH临床管理无显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Apocrine change is common in breast pathology, yet atypical apocrine lesions remain poorly defined and diagnostically challenging. This study aimed to clarify the terminology of atypical apocrine proliferations and assess their clinical significance by correlating histologic features with clinical outcomes. METHODS: We retrospectively analyzed 59 specimens initially diagnosed as atypical apocrine adenosis (AAA) or atypical apocrine hyperplasia (AAH), including apocrine atypical ductal hyperplasia, from 2014 to 2024. Cases with coexisting in situ or invasive ductal carcinoma were excluded. Histologic features and clinical follow-up data were reviewed. RESULTS: No significant differences were observed between AAA and AAH with respect to patient age, lesional size, most architectural patterns, lobular involvement, nuclear features, necrosis, calcifications, or carcinoma upstaging on subsequent excision. Cribriform architecture was significantly more frequent in AAH than AAA (63% vs. 33%, p = 0.047). Lesions upstaged to in situ or invasive ductal carcinoma demonstrated a significantly larger extent of atypia on biopsy (1.3 cm vs. 0.8 cm, p = 0.043), higher frequencies of marked nuclear enlargement (≥3-fold compared with background epithelium; 92% vs. 54%, p = 0.027), nuclear irregularity (54% vs. 17%, p = 0.028), and necrosis (23% vs. 0%, p = 0.037). Lesional extent, nuclear irregularity, and necrosis were independently associated with carcinoma upstaging (p < 0.05). CONCLUSIONS: Cribriform architecture supports classification as AAH, though AAA and AAH show no significant clinical differences. Marked nuclear enlargement, nuclear irregularity, and necrosis in larger atypical apocrine lesions are strongly associated with carcinoma upstaging and should prompt consideration of apocrine DCIS.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Podany P, Zhan H, Colón-Cartagena L, et al. Histomorphologic analysis and clinical correlation of atypical apocrine lesions in breast pathology. Hum Pathol. 2026. PMID: 42176994. doi:10.1016/j.humpath.2026.106158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。